Findings

What do systematic reviews say?

Refine by population, intervention, comparison or outcome
More filters
Evidence found and GRADE certainty

3,747 questions · 3,943 findings · 594 reviews

No studies found 784 · 19.9%GRADE not reported 530 · 13.4%Very low 1,040 · 26.4%Low 981 · 24.9%Moderate 444 · 11.3%High 164 · 4.2%

Community and caregiver oral health education plus media campaign vs Pre-intervention BBTD rate

Baby bottle tooth decay prevalence · Alaska Native and American Indian Head Start children

High-intensity community education was associated with a 33% reduction in BBTD prevalence, without a GRADE rating.

3 findings from 1 review

Community and caregiver oral health education plus media campaign vs Pre-intervention baseline (and sites that discontinued the prevention program)

Reduction in prevalence of baby bottle tooth decay (BBTD) · Alaska Native and American Indian Head Start children

Community and caregiver oral health education was associated with a significant ~25% overall reduction in baby bottle tooth decay among Head Start children (certainty not graded).

1 finding from 1 review

Ongoing BBTD Prevention Program vs BBTD Prevention Program discontinued in 1989

Baby bottle tooth decay prevalence · Alaska Native and American Indian Head Start children

Sites discontinuing the prevention program had a non-significant 15% reduction in tooth decay rate, without a GRADE rating.

2 findings from 1 review

Cyclophosphamide vs methylprednisolone

Response to treatment (20% improvement)* · patients with neuropsychiatric involvement in systemic lupus erythematosus

It is very uncertain whether cyclophosphamide changes response to treatment (20% improvement)* compared with methylprednisolone (very low certainty).

1 finding from 1 review

Cyclophosphamide vs methylprednisolone

Urinary tract infection · patients with neuropsychiatric involvement in systemic lupus erythematosus

It is very uncertain whether cyclophosphamide changes adverse events ‐ Urinary tract infections compared with methylprednisolone (very low certainty).

1 finding from 1 review

Cyclophosphamide vs methylprednisolone

Adverse events ‐ Death · patients with neuropsychiatric involvement in systemic lupus erythematosus

It is very uncertain whether cyclophosphamide changes adverse events ‐ Death compared with methylprednisolone (very low certainty).

1 finding from 1 review

Intervention not reported

Perioperative bleeding requiring non‐surgical intervention · patients with paediatric tonsillectomy

The intervention showed no clear difference in perioperative bleeding requiring non‐surgical intervention (moderate certainty).

1 finding from 1 review

Intervention not reported

the toxic and side effects in digestive system after chemotherapy (no special data in trial of Zhang 2006) · patients with induction of remission in advanced or late gastric cancer

It is very uncertain whether the intervention changes the toxic and side effects in digestive system after chemotherapy… (very low certainty).

1 finding from 1 review

Intervention not reported

the rate of complete remission and partly remission · patients with induction of remission in advanced or late gastric cancer

It is very uncertain whether the intervention changes the rate of complete remission and partly remission (very low certainty).

1 finding from 1 review

Intervention not reported

the toxic and side effects in digestive system after chemotherapy · patients with induction of remission in advanced or late gastric cancer

It is very uncertain whether the intervention changes the toxic and side effects in digestive system after chemotherapy (very low certainty).

1 finding from 1 review

Intervention not reported

the toxic and side effects of leukopenia after chemotherapy · patients with induction of remission in advanced or late gastric cancer

It is very uncertain whether the intervention changes the toxic and side effects of leukopenia after chemotherapy (very low certainty).

1 finding from 1 review